MedTrace Logo

Effects of Remimazolam on Quality of Recovery After Ambulatory Surgery

NCT05320016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2022-04-11

No results posted yet for this study

Summary

Remimazolam is a novel ultra-short acting benzodiazepine with rapid onset of effects, short maintenance and faster recovery time. Due to its recent development, few studies have investigated the effect of remimazolam on postoperative recovery mainly focusing on physiologic endpoints, recovery time and possible adverse events. Although these parameters are crucial and need evaluation, the investigators ignore quality of recovery from participant's perspective. For this purpose, various measurment tools have been developed for psychometric evaluation of QoR score.

Conditions

  • Day Surgery
  • Patient Outcome Assessment
  • Quality of Recovery
  • Remimazolam

Interventions

DRUG

Remimazolam

Effects of remimazolam on quality of recovery scores after ambulatory hysteroscopic surgery

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Sang-Hwan Do · Seoul National University Bundang Hospital

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05320016 on ClinicalTrials.gov